RenovoRx is developing innovative solutions for targeted delivery of fluids, including radiopaque material and therapeutic agents, to selected sites in the peripheral vascular system. The ability to deliver these materials at high concentration to specific visceral organs, safely and without perfusion overlap to other organs, is a central paradigm of our technology. RenovoRx is a very lean startup, operating through a capital efficient model.

Back to Companies

Shaun Begai